Zhejiang Medicine Co., Ltd. v. Kaneka Corporation, No. 16-1390 (Fed. Cir. Jan. 23, 2017)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Kaneka Corporation (“Kaneka”) appeals from the Southern District of Texas’ summary judgment of noni n- fringement of all ass erted claims of U.S. Patent No. 7,910,340 (“the ’340 patent”). For the reasons di s- cussed below, we vacate and remand. BACKGROUND The ’340 patent is directed to an industrial process for producing oxidized coenzyme Q10 (“CoQ10”), an antioxidant used in health supplements. Kaneka brought suit against Zhejiang Medicine Co., Ltd.